FI950439A0 - 3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät - Google Patents

3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät

Info

Publication number
FI950439A0
FI950439A0 FI950439A FI950439A FI950439A0 FI 950439 A0 FI950439 A0 FI 950439A0 FI 950439 A FI950439 A FI 950439A FI 950439 A FI950439 A FI 950439A FI 950439 A0 FI950439 A0 FI 950439A0
Authority
FI
Finland
Prior art keywords
deoxythymidine
controlled release
pct
azt
azido
Prior art date
Application number
FI950439A
Other languages
English (en)
Swedish (sv)
Other versions
FI950439A (fi
Inventor
James M Dunn
Original Assignee
James M Dunn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James M Dunn filed Critical James M Dunn
Publication of FI950439A0 publication Critical patent/FI950439A0/fi
Publication of FI950439A publication Critical patent/FI950439A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI950439A 1992-08-04 1995-02-01 3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät FI950439A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92447692A 1992-08-04 1992-08-04
PCT/US1993/007308 WO1994003471A1 (en) 1992-08-04 1993-08-04 Controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine and methods of use

Publications (2)

Publication Number Publication Date
FI950439A0 true FI950439A0 (fi) 1995-02-01
FI950439A FI950439A (fi) 1995-02-01

Family

ID=25450250

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950439A FI950439A (fi) 1992-08-04 1995-02-01 3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät

Country Status (8)

Country Link
US (1) US5681581A (fi)
EP (1) EP0654038B1 (fi)
AT (1) ATE186544T1 (fi)
AU (1) AU677220B2 (fi)
CA (1) CA2141788C (fi)
DE (1) DE69327004T2 (fi)
FI (1) FI950439A (fi)
WO (1) WO1994003471A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
US6576231B2 (en) * 1997-09-12 2003-06-10 Schering Ag Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor
US6309632B1 (en) 1998-04-28 2001-10-30 Immunex Corporation Methods for treating HIV-infected patients by administering GM-CSF
BR0013719A (pt) * 1999-09-02 2002-07-23 Nostrum Pharmaceuticals Inc Dosagem oral de liberaçâo controlada, apropriada para administração oral
US20030050620A1 (en) * 2001-09-07 2003-03-13 Isa Odidi Combinatorial type controlled release drug delivery device
WO2003090762A1 (en) * 2002-04-23 2003-11-06 Lupin Limited Long acting compositions comprising zidovudine and lamivudine
CA2505130C (en) * 2002-11-08 2009-10-06 Glaxo Group Limited Pharmaceutical compositions
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2009037449A1 (en) * 2007-09-18 2009-03-26 Cipla Limited Solid pharmaceutical compositions comprising one or more herpes virus inhibitors and one or more reverse transcriptase inhibitors
US10940113B2 (en) * 2017-02-24 2021-03-09 Medical And Pharmaceutical Industry Technology And Development Center Pharmaceutical composition for colon targeting, method for treating a colon-related disease using the same and preparation method thereof
GB2595203A (en) 2020-03-03 2021-11-24 Alkaloid Ad Skopje Formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78826A (en) * 1986-05-19 1991-05-12 Yissum Res Dev Co Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom
ATE71293T1 (de) * 1986-09-18 1992-01-15 London Pharmacy Innovation Arzneiformulierung.
GB8706176D0 (en) * 1987-03-16 1987-04-23 Wellcome Found Therapeutic nucleosides
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
EP0654038A4 (en) 1996-02-28
ATE186544T1 (de) 1999-11-15
DE69327004D1 (de) 1999-12-16
US5681581A (en) 1997-10-28
EP0654038A1 (en) 1995-05-24
WO1994003471A1 (en) 1994-02-17
AU677220B2 (en) 1997-04-17
CA2141788A1 (en) 1994-02-17
FI950439A (fi) 1995-02-01
DE69327004T2 (de) 2000-06-29
EP0654038B1 (en) 1999-11-10
CA2141788C (en) 2001-12-11
AU4801593A (en) 1994-03-03

Similar Documents

Publication Publication Date Title
FI950439A0 (fi) 3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät
RS49577B (sr) Formulacije analoga insulina
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
ATE63818T1 (de) 3'-azido-3'-deoxythymidin-formulierungen mit gesteuerter freigabe.
PA8443001A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
BR0113961A (pt) Método de analgesia
HUP0103255A2 (hu) Mitokondriális betegségek kezelésére szolgáló eljárások és készítmények
ES2188666T3 (es) Analogos de la distamicina utilies como agentes antitumorales o antivirales.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
BR9607109A (pt) Emprego de 5'nucleosídeos substituidos para a formação de resisténcia no tratamento de citostáticos e medicamentos contendo estes nucleosídeos
BR9811876A (pt) Uso de compostos contendo citidina e contendo citosina como tratamento para exposiçào a estimulante
FI970147A (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
BR0011174A (pt) Composições, compostos, compostos isolados e métodos para controlar pestes
NO953353D0 (no) Xantinderivater som adenosin-A -reseptorantagonister
DK0865271T4 (da) Anvendelse af 2-ethylhexyl alfa-cyano-beta, beta-diphenylacrylat med henblik på at forbedre stabiliteten over for lys af p-methylbenzyliden-kamfer
DE69914757D1 (de) Parfümzusammensetzung
BR0316054A (pt) Compostos para tratamento de dependência e privação de tabaco
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
MX9305016A (es) Metodo para inhibir la replicacion hiv utilizando il-4.
DE60207824D1 (de) Cytidin-diphosphocholin gegen diabetische neuropathie
NO950388L (no) Kontrollert frigjorte farmasöytiske formuleringer av 3'-azido-3'-deoksythythymidin og metoder for anvendelse
ES2085023T3 (es) Procedimientos para la produccion de zidovudina.
SE9001592L (sv) Terapeutisk komposition